CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online 2014 March 26 DOI: https://doi.org/10.3350/cmh.2014.20.1.38

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clinical and Molecular Hepatology. 2014;20(1):38

Link1 Link2 Link3

Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients

Steven Herrine

Therapeutics and Clinical Risk Management. 2008;Volume 4:789-796

Link1 Link2

Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infection

G. BORRONI, M. ANDREOLETTI, M. A. CASIRAGHI, R. CERIANI, P. GUERZONI, B. OMAZZI, N. TERRENI, F. SALERNO

Alimentary Pharmacology & Therapeutics. 2008;27(9):790-797

Link1 Link2

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin

Olav Dalgard

Pharmacogenomics and Personalized Medicine. 2010;1

Link1

13 Impact of Diet and Exercise Intervention On Insulin Resistance and Early Virological Response to Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis C

Yasunori Kawaguchi, Toshihiko Mizuta, Takuya Kuwashiro, Noriko Oza, Hirokazu Takahashi, Yuichiro Eguchi, Iwata Ozaki, Kazuma Fujimoto

Gastroenterology. 2009;136(5):A-791

Link1 Link2

Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

Mitchell L. Shiffman

Current Hepatitis Reports. 2006;5(3):114-120

Link1

Link2 Link3

Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a

Waqas Gulzar, Zafar Niaz, Sami Ullah Mumtaz, Somia Iqtadar, Tayyeba Komal, Sajid AbaidUllah

Pakistan BioMedical Journal. 2019;2(1):

Link1 Link2

772 COMBINATION USE OF INTERFERON-BETA WITH DOUBLE FILTRATION PLASMAPHERESIS FOR THE CHRONIC HEPATITIS C PATIENTS WITH REFRACTORY TO PEGYLATED INTERFERON A-2B / RIBAVIRIN COMBINATION THERAPY

K. Takaguchi, N. Baba, T. Seno, T. Nagano

Journal of Hepatology. 2010;52:S300

Link1 Link2

Impact of early elevation of serum bilirubin during treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C

Masatoshi Ishigami, Kazuhiko Hayashi, Yoshiaki Katano, Akihiro Itoh, Yoshiki Hirooka, Hidemi Goto

Hepatology Research. 2010;40(10):963-970

Link1 Link2

1142 INCREASED BONE MINERAL DENSITY IN CHRONIC HEPATITIS C PATIENTS AFTER TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION

C. Bunchorntavakul, W. Chotiyaputta, S. Nimanong, S. Chainuvati, P. Charatcharoenwitthaya, S. Sriussadaporn, T. Tanwandee

Journal of Hepatology. 2011;54:S451

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.